EP0833904A4 - Fibroblasten-wachstumsfaktor-14 - Google Patents

Fibroblasten-wachstumsfaktor-14

Info

Publication number
EP0833904A4
EP0833904A4 EP95921454A EP95921454A EP0833904A4 EP 0833904 A4 EP0833904 A4 EP 0833904A4 EP 95921454 A EP95921454 A EP 95921454A EP 95921454 A EP95921454 A EP 95921454A EP 0833904 A4 EP0833904 A4 EP 0833904A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
fibroblast growth
fibroblast
factor
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95921454A
Other languages
English (en)
French (fr)
Other versions
EP0833904A1 (de
Inventor
John M Greene
Patrick J Dillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0833904A1 publication Critical patent/EP0833904A1/de
Publication of EP0833904A4 publication Critical patent/EP0833904A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP95921454A 1995-06-05 1995-06-05 Fibroblasten-wachstumsfaktor-14 Withdrawn EP0833904A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002212992A CA2212992A1 (en) 1995-06-05 1995-06-05 Fibroblast growth factor-14
PCT/US1995/006730 WO1996039506A1 (en) 1995-06-05 1995-06-05 Fibroblast growth factor-14

Publications (2)

Publication Number Publication Date
EP0833904A1 EP0833904A1 (de) 1998-04-08
EP0833904A4 true EP0833904A4 (de) 2000-05-17

Family

ID=25679546

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95921454A Withdrawn EP0833904A4 (de) 1995-06-05 1995-06-05 Fibroblasten-wachstumsfaktor-14

Country Status (4)

Country Link
EP (1) EP0833904A4 (de)
AU (1) AU702131B2 (de)
CA (1) CA2212992A1 (de)
WO (1) WO1996039506A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6787640B2 (en) 1995-06-05 2004-09-07 Human Genome Sciences, Inc. Fibroblast growth factor 14
IL126298A0 (en) * 1996-03-21 1999-05-09 Jons Hopkins University School Fibroblast growht factor homologous factor-3 (fhf-3) and method of use
US6020189A (en) 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
CN1311212A (zh) * 2000-03-02 2001-09-05 上海博德基因开发有限公司 一种新的多肽——人成纤维细胞生长因子14和编码这种多肽的多核苷酸
CA2631765C (en) 2005-12-02 2017-06-27 The Scripps Research Institute Angiogenic tyrosyl trna synthetase compositions and methods
WO2012021249A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
JP5964304B2 (ja) 2010-08-25 2016-08-03 エータイアー ファーマ， インコーポレイテッド チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
WO2013123432A2 (en) 2012-02-16 2013-08-22 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
CA2907046C (en) 2013-03-15 2021-04-20 Atyr Pharma, Inc. Histidyl-trna synthetase-fc conjugates
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002131010, Database accession no. T27215 *
GOSPODAROWICZ, D.: "Fibroblast growth factors: from genes to clinical applications", CELL BIOLOGY REVIEWS, vol. 25, no. 4, 1991, pages 307 - 314, XP002058994 *
See also references of WO9639506A1 *
SMALLWOOD, P.M. ET AL.: "Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, no. 18, 3 September 1996 (1996-09-03), pages 9850 - 9857, XP002058996 *

Also Published As

Publication number Publication date
WO1996039506A1 (en) 1996-12-12
CA2212992A1 (en) 1996-12-12
EP0833904A1 (de) 1998-04-08
AU702131B2 (en) 1999-02-11
AU2653095A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
EP0871705A4 (de) Menschlicher ccn-ähnlicher wachstumsfaktor
HUP9600648A3 (en) Palette-container
EP0721767A3 (de) Endoprothese
EP0904292A4 (de) Wachstums-differenzierungsfaktor-14
EP0833904A4 (de) Fibroblasten-wachstumsfaktor-14
EP0832215A4 (de) Fibroblasten-wachstumsfaktor 11
AU2697995A (en) Fibroblast growth factor 13
EP0832216A4 (de) Fibroblaster wachstumsfaktor
ZA967201B (en) Piperidinylmethyloxazolidinone
AP9600802A0 (en) Libricant
EP0891372A4 (de) Wachstumfaktor httr36
GB9424232D0 (en) Growth factor expression
AU2002301359A1 (en) Fibroblast Growth Factor 15
AU2002300809A1 (en) Fibroblast Growth Factor 11
GB9611417D0 (en) Prosthesis
CA76097S (en) Can
AU1105P (en) DALESE Metrosideros excelsus
GB9619489D0 (en) Growth factors
GB9517404D0 (en) Prosthesis
GB9520009D0 (en) Prosthesis
GB9503820D0 (en) Prosthesis
GB9511227D0 (en) Prosthesis
GB9517403D0 (en) Prosthesis
GB9719794D0 (en) Growth Factors
ZA9810781B (en) Fibroblast growth factor-19.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971002

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000329

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20010806

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

APAA Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050225

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE